Cargando…
LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia
Although great advances have been made in understanding the pathobiology of mixed lineage leukemia-rearranged (MLL-r) leukemias, therapies for this leukemia have remained limited, and clinical outcomes remain bleak. In order to identify novel targets for immunotherapy treatments, we compiled a linea...
Autores principales: | Gracia-Maldonado, Gabriel, Clark, Jason, Burwinkel, Matthew, Greenslade, Brenay, Wunderlich, Mark, Salomonis, Nathan, Leone, Dario, Gatti, Evelina, Pierre, Philippe, Kumar, Ashish R., Lee, Lynn H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968879/ https://www.ncbi.nlm.nih.gov/pubmed/33910331 http://dx.doi.org/10.3324/haematol.2020.257451 |
Ejemplares similares
-
MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
por: Itskovich, Svetlana S., et al.
Publicado: (2020) -
Publisher Correction: MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia
por: Itskovich, Svetlana S., et al.
Publicado: (2020) -
Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia
por: Sharma, Amit, et al.
Publicado: (2020) -
Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib
por: Zámečníkova, Adriana
Publicado: (2011) -
The developmental stage of the hematopoietic niche regulates lineage in MLL-rearranged leukemia
por: Rowe, R. Grant, et al.
Publicado: (2019)